Pharmaceutical compositions for nasal delivery

Details for Australian Patent Application No. 2010202623 (hide)

Owner Britannia Pharmaceuticals Limited

Inventors Merkus, Franciscus W.H.; Adams, Gerald; Lambert, Peter Alan

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2010202623

Parent 2004216458

Filing date 23 June 2010

Wipo publication date 15 July 2010

International Classifications

A61K 31/48 (2006.01) - Ergoline derivatives, e.g. lysergic acid, ergotamine

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/19 (2006.01) Medicinal preparations characterised by special physical form - lyophilised

A61K 31/485 (2006.01) - Morphinan derivatives, e.g. morphine, codeine

A61K 47/26 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carbohydrates

Event Publications

8 July 2010 Complete Application Filed

15 July 2010 Application Open to Public Inspection

  Published as AU-A-2010202623

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010202624-A gaming system and a method of gaming

2010202622-Novel melon plants